HERON THERAPEUTICS INC HERON TH (0J4V.L) Financials

0J4V.L Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 229.2 million 257.0 million
2023-06-30 201.2 million 240.5 million
2023-03-31 220.9 million 232.3 million
2022-12-31 251.0 million 237.4 million

0J4V.L Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -10.0 million 6.7 million
2023-06-30 -27.4 million 13.9 million
2023-03-31 -25.1 million 7.9 million
2022-12-31 -37.9 million 10.5 million

0J4V.L Net Income

No data available :(

0J4V.L Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 77.4 million - -
2023-06-30 33.2 million - -
2023-03-31 60.0 million - -
2022-12-31 84.9 million - -

0J4V.L Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 145.0 million
2023-06-30 119.7 million
2023-03-31 119.2 million
2022-12-31 119.2 million

0J4V.L Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 793000 13.6 million 9.4 million 12.0 million
2023-06-30 278000 17.6 million 10.1 million 16.2 million
2023-03-31 224000 13.8 million 10.9 million 21.2 million
2022-12-31 414000 11.1 million 8.7 million 16.8 million

0J4V.L Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 31.4 million 18.2 million
2023-06-30 31.8 million 20.2 million
2023-03-31 29.6 million 16.9 million
2022-12-31 30.0 million 12.6 million

0J4V.L

Price: $3.26

52 week price:
0.54
3.26

Earnings Per Share: -2.29 USD

P/E Ratio: -1.01

Exchange: LSE

Sector: Healthcare

Industry: Pharmaceuticals, Biotechnology & Life Sciences

Market Capitalization: 2.3 million

Links: